177 related articles for article (PubMed ID: 35002525)
1. The cross-talk between PARylation and SUMOylation in C/EBPβ at K134 site participates in pathological cardiac hypertrophy.
Wang L; Wang P; Xu S; Li Z; Duan DD; Ye J; Li J; Ding Y; Zhang W; Lu J; Liu P
Int J Biol Sci; 2022; 18(2):783-799. PubMed ID: 35002525
[TBL] [Abstract][Full Text] [Related]
2. The poly(ADP-ribosyl)ation of FoxO3 mediated by PARP1 participates in isoproterenol-induced cardiac hypertrophy.
Lu J; Zhang R; Hong H; Yang Z; Sun D; Sun S; Guo X; Ye J; Li Z; Liu P
Biochim Biophys Acta; 2016 Dec; 1863(12):3027-3039. PubMed ID: 27686254
[TBL] [Abstract][Full Text] [Related]
3. PARP-1 Controls the Adipogenic Transcriptional Program by PARylating C/EBPβ and Modulating Its Transcriptional Activity.
Luo X; Ryu KW; Kim DS; Nandu T; Medina CJ; Gupte R; Gibson BA; Soccio RE; Yu Y; Gupta RK; Kraus WL
Mol Cell; 2017 Jan; 65(2):260-271. PubMed ID: 28107648
[TBL] [Abstract][Full Text] [Related]
4. The poly(ADP-ribosyl)ation of BRD4 mediated by PARP1 promoted pathological cardiac hypertrophy.
Li Z; Guo Z; Lan R; Cai S; Lin Z; Li J; Wang J; Li Z; Liu P
Acta Pharm Sin B; 2021 May; 11(5):1286-1299. PubMed ID: 34094834
[TBL] [Abstract][Full Text] [Related]
5. PARP1 interacts with HMGB1 and promotes its nuclear export in pathological myocardial hypertrophy.
Li Q; Li ZM; Sun SY; Wang LP; Wang PX; Guo Z; Yang HW; Ye JT; Lu J; Liu PQ
Acta Pharmacol Sin; 2019 May; 40(5):589-598. PubMed ID: 30030529
[TBL] [Abstract][Full Text] [Related]
6. The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1.
Fischbach A; Krüger A; Hampp S; Assmann G; Rank L; Hufnagel M; Stöckl MT; Fischer JMF; Veith S; Rossatti P; Ganz M; Ferrando-May E; Hartwig A; Hauser K; Wiesmüller L; Bürkle A; Mangerich A
Nucleic Acids Res; 2018 Jan; 46(2):804-822. PubMed ID: 29216372
[TBL] [Abstract][Full Text] [Related]
7. Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.
Alemasova EE; Lavrik OI
Nucleic Acids Res; 2019 May; 47(8):3811-3827. PubMed ID: 30799503
[TBL] [Abstract][Full Text] [Related]
8. PIASy mediates SUMO-2/3 conjugation of poly(ADP-ribose) polymerase 1 (PARP1) on mitotic chromosomes.
Ryu H; Al-Ani G; Deckert K; Kirkpatrick D; Gygi SP; Dasso M; Azuma Y
J Biol Chem; 2010 May; 285(19):14415-23. PubMed ID: 20228053
[TBL] [Abstract][Full Text] [Related]
9. Modulation of inducible nitric oxide synthase expression by sumoylation.
Akar CA; Feinstein DL
J Neuroinflammation; 2009 Mar; 6():12. PubMed ID: 19323834
[TBL] [Abstract][Full Text] [Related]
10. PARP1 interacts with STAT3 and retains active phosphorylated-STAT3 in nucleus during pathological myocardial hypertrophy.
Wang L; Li Z; Tan Y; Li Q; Yang H; Wang P; Lu J; Liu P
Mol Cell Endocrinol; 2018 Oct; 474():137-150. PubMed ID: 29501586
[TBL] [Abstract][Full Text] [Related]
11. miR-146a Suppresses SUMO1 Expression and Induces Cardiac Dysfunction in Maladaptive Hypertrophy.
Oh JG; Watanabe S; Lee A; Gorski PA; Lee P; Jeong D; Liang L; Liang Y; Baccarini A; Sahoo S; Brown BD; Hajjar RJ; Kho C
Circ Res; 2018 Aug; 123(6):673-685. PubMed ID: 30355233
[TBL] [Abstract][Full Text] [Related]
12. SUMOylation of XRCC1 activated by poly (ADP-ribosyl)ation regulates DNA repair.
Hu LY; Chang CC; Huang YS; Chou WC; Lin YM; Ho CC; Chen WT; Shih HM; Hsiung CN; Wu PE; Shen CY
Hum Mol Genet; 2018 Jul; 27(13):2306-2317. PubMed ID: 29668892
[TBL] [Abstract][Full Text] [Related]
13. Regulation of Poly(ADP-Ribose) Polymerase 1 Activity by Y-Box-Binding Protein 1.
Naumenko KN; Sukhanova MV; Hamon L; Kurgina TA; Alemasova EE; Kutuzov MM; Pastré D; Lavrik OI
Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32947956
[TBL] [Abstract][Full Text] [Related]
14. Real-time monitoring of PARP1-dependent PARylation by ATR-FTIR spectroscopy.
Krüger A; Bürkle A; Hauser K; Mangerich A
Nat Commun; 2020 May; 11(1):2174. PubMed ID: 32358582
[TBL] [Abstract][Full Text] [Related]
15. Metabolic impairment in response to early induction of C/EBPβ leads to compromised cardiac function during pathological hypertrophy.
Banerjee D; Datta Chaudhuri R; Niyogi S; Roy Chowdhuri S; Poddar Sarkar M; Chatterjee R; Chakrabarti P; Sarkar S
J Mol Cell Cardiol; 2020 Feb; 139():148-163. PubMed ID: 31958467
[TBL] [Abstract][Full Text] [Related]
16. Poly(ADP-ribose) polymerase 1 induces cardiac fibrosis by mediating mammalian target of rapamycin activity.
Sun S; Hu Y; Zheng Q; Guo Z; Sun D; Chen S; Zhang Y; Liu P; Lu J; Jiang J
J Cell Biochem; 2019 Apr; 120(4):4813-4826. PubMed ID: 29278652
[TBL] [Abstract][Full Text] [Related]
17. Poly(ADP-ribosyl)ation enhances HuR oligomerization and contributes to pro-inflammatory gene mRNA stabilization.
Ke Y; Lv X; Fu X; Zhang J; Bohio AA; Zeng X; Hao W; Wang R; Boldogh I; Ba X
Cell Mol Life Sci; 2021 Feb; 78(4):1817-1835. PubMed ID: 32789690
[TBL] [Abstract][Full Text] [Related]
18. SUMO1-dependent modulation of SERCA2a in heart failure.
Kho C; Lee A; Jeong D; Oh JG; Chaanine AH; Kizana E; Park WJ; Hajjar RJ
Nature; 2011 Sep; 477(7366):601-5. PubMed ID: 21900893
[TBL] [Abstract][Full Text] [Related]
19. Protein inhibitor of activated STAT 1 (PIAS1) is identified as the SUMO E3 ligase of CCAAT/enhancer-binding protein β (C/EBPβ) during adipogenesis.
Liu Y; Zhang YD; Guo L; Huang HY; Zhu H; Huang JX; Liu Y; Zhou SR; Dang YJ; Li X; Tang QQ
Mol Cell Biol; 2013 Nov; 33(22):4606-17. PubMed ID: 24061474
[TBL] [Abstract][Full Text] [Related]
20. Poly(ADP-ribosyl)ation of acetyltransferase NAT10 by PARP1 is required for its nucleoplasmic translocation and function in response to DNA damage.
Liu HY; Liu YY; Zhang YL; Ning Y; Zhang FL; Li DQ
Cell Commun Signal; 2022 Aug; 20(1):127. PubMed ID: 35986334
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
